Scarica l'app Stockscreener
29.95
1.70%
0.50
Dopo l'orario di chiusura:
30.20
0.25
+0.83%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Pfizer Inc Borsa (PFE) Ultime notizie
GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth? - Zacks Investment Research
BMY Q3 Earnings Tops Estimates, Higher Charges Weigh on Outlook - Zacks Investment Research
Merck (MRK) Surpasses Q3 Earnings and Revenue Estimates - Zacks Investment Research
Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight - GlobeNewswire Inc.
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now - The Motley Fool
Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings - Zacks Investment Research
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards? - Zacks Investment Research
Pfizer shares may move 3.8% on Nov. 3 earnings release - Investing.com
Pfizer's ELREXFIO meets Phase 3 myeloma endpoint - Mugglehead Investment Magazine
Pfizer posts late-stage trial win for multiple myeloma drug Elrexfio in an earlier line setting - Seeking Alpha
Pfizer’s ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma - Business Wire
Pfizer Inc (PFE) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
Pfizer Inc. Receives FDA Expanded Approval for TALZENNA Plus XTANDI for HRR Gene-Mutated Metastatic Androgen Pathway Modulation-Naïve or -Sensitive Prostate Cancer - www.marketscreener.com
Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? - Zacks Investment Research
Can Pfizer Stock Get Back To Where It Was? - Trefis
Pfizer Inc. (1PFE.MI) stock price, news, quote and history - Yahoo Finance UK
Pfizer Inc. : Gets a Buy rating from Jefferies - marketscreener.com
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants - Contagion Live
Pfizer Sees Path Forward for Cancer Drug Despite Trial Failure - Bloomberg.com
Pfizer Inc. Advanced Charts | PFE - Barron's
Pfizer details 25‑strain infant vaccine data as pivotal trials advance - Mugglehead Investment Magazine
Amgen vs. Johnson & Johnson: Which Healthcare Giant Has the Better Stock to Buy? - The Motley Fool
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026 - Business Wire
Micro Pfizer Inc Stock Futures, (XPFE0=F) stock price, news, quote and history - Yahoo Finance UK
Pfizer Inc. (PFE) Company Profile & Facts - Yahoo! Finance Canada
Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb? - The Motley Fool
Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy? - The Motley Fool
Micro Pfizer Inc Stock Futures, (XPFE0Z26.CME) Interactive Stock ChartYahoo Finance - Yahoo! Finance Canada
Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue - The Motley Fool
Pfizer stock hits 52-week high at 30.26 USD By Investing.com - Investing.com South Africa
Pfizer Inc. Research & Ratings | PFE - Barron's
Pfizer Inc. stock has November 3 call, slightly higher pre-market - AD HOC NEWS
Pfizer announces layoffs at NC facilities, leaving workers and local leaders seeking answers - Yahoo Finance
Pfizer, Inc. (PFE) Stock forecasts - Yahoo Finance UK
Global Oral Drugs Market is Predicted to Surpass USD 1 Trillion Mark by 2034 | DelveInsight - GlobeNewswire Inc.
Pfizer stock: BofA raises target for Pfizer stock to USD 29.00 - AD HOC NEWS
Will Auvelity Continue to Aid Axsome's Top-Line Growth in Q3? - Zacks Investment Research
Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio? - Zacks Investment Research
Bank of America raises target to USD 29 for Pfizer stock - AD HOC NEWS
Forget COVID: Moderna Is Turning Into a Cancer Company -- and Wall Street Is Taking Notice - The Motley Fool
Is Pfizer (NYSE:PFE) Positioned for Renewed Healthcare Sector Attention? - Kalkine Media
Micro Pfizer Inc Stock Futures, (XPFE0H27.CME) stock historical prices and data - Yahoo Finance UK
Lobbying Update: $3,600,000 of PFIZER INC. lobbying was just disclosed - Quiver Quantitative
Pfizer, Inc. (PFE) Stock Forecasts - Yahoo! Finance Canada
Pfizer, Inc. (PFE) Stock Forecasts - Yahoo Finance
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing - Zacks Investment Research
Ex-White House, Pfizer Execs Squelch Vaccine Skeptic’s Appeal - Bloomberg Law News
GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth - Zacks Investment Research
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It - Zacks Investment Research
2.22%
0.12%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):